General disclaimer
The content contained in this blog represents the opinions of Mr. Hempton. You should assume Mr. Hempton and his affiliates have positions in the securities discussed in this blog, and such beneficial ownership can create a conflict of interest regarding the objectivity of this blog. Statements in the blog are not guarantees of future performance and are subject to certain risks, uncertainties and other factors. Certain information in this blog concerning economic trends and performance is based on or derived from information provided by third-party sources. Mr. Hempton does not guarantee the accuracy of such information and has not independently verified the accuracy or completeness of such information or the assumptions on which such information is based. Such information may change after it is posted and Mr. Hempton is not obligated to, and may not, update it. The commentary in this blog in no way constitutes a solicitation of business, an offer of a security or a solicitation to purchase a security, or investment advice. In fact, it should not be relied upon in making investment decisions, ever. It is intended solely for the entertainment of the reader, and the author. In particular this blog is not directed for investment purposes at US Persons.
7 comments:
Ha ha ha.
Oh dear. A nice long rant (incomplete) but there's a very simple moral: incomplete disclosure should be a warning!
1. VRX declined to disclose revenue segmentation by products after acquisition(the only one to do this in industry), making it almost impossible to track product revenue growth; After digging, he suspects some of revenues may be inflated.
2. they used average CAGR instead of weighted average CAGR to inflate growth number of their acquisitions.
Conclusion: don't trust the management.
Investors falling in droves for an amazingly advertised company with opaque accounting hiding unsustainable business performance?
Oh my god, what a news! )))
Classic pattern for these companies:
a) they tend to present themselves as discoverers and sole beneficiaries of a certain business optimization strategy which actually contains absolutely nothing new. (Be that "buying undervalued oil land", "saving on RnD costs in pharma", or "giving people discounts")
b) they tend to claim that strategy working based on a couple of years of operations for which they provide opaque/misleading/non-GAAP reporting.
c) they adamantly deny comparisons to "conventional" businesses in the field, referring to a)
So far, it's not really one for 10-K nuts. One of the early points being that VRX is not putting enough information in their 10-K to allow meaningful analysis of acquisition performance.
At least there is some Attachment to reality. Some companies like SunEdison in particular are in total fantasy land.
So John, are you short VRX?
Extremely insightful case study.
Post a Comment